| Perspectives of TRPV1 function on the neurogenesis and neural plasticity R Ramírez-Barrantes, C Cordova, H Poblete, P Muñoz, I Marchant, ... Neural Plasticity 2016, 2016 | 58 | 2016 |
| Intracellular aggregated TRPV1 is associated with lower survival in breast cancer patients C Lozano, C Córdova, I Marchant, R Zúñiga, P Ochova, ... Breast Cancer: Targets and Therapy, 161-168, 2018 | 40 | 2018 |
| Impact of aldosterone antagonists on sudden cardiac death prevention in heart failure and post-myocardial infarction patients: a systematic review and meta-analysis of … HH Le, C El-Khatib, M Mombled, F Guitarian, M Al-Gobari, M Fall, ... PLoS One 11 (2), e0145958, 2016 | 38 | 2016 |
| Transient receptor potential vanilloid 1 expression mediates capsaicin-induced cell death R Ramírez-Barrantes, C Córdova, S Gatica, B Rodriguez, C Lozano, ... Frontiers in physiology 9, 360861, 2018 | 37 | 2018 |
| Virtual patients and sensitivity analysis of the Guyton model of blood pressure regulation: towards individualized models of whole-body physiology R Moss, T Grosse, I Marchant, N Lassau, F Gueyffier, SR Thomas PLoS Computational Biology 8 (6), e1002571, 2012 | 31 | 2012 |
| SCORE should be preferred to Framingham to predict cardiovascular death in French population I Marchant, JP Boissel, B Kassaï, T Bejan, J Massol, C Vidal, E Amsallem, ... European Journal of Preventive Cardiology 16 (5), 609-615, 2009 | 27 | 2009 |
| The global risk approach should be better applied in French hypertensive patients: a comparison between simulation and observation studies I Marchant, P Nony, M Cucherat, JP Boissel, SR Thomas, ... PLoS One 6 (3), e17508, 2011 | 24 | 2011 |
| Proteostasis and mitochondrial role on psychiatric and neurodegenerative disorders: current perspectives P Olivero, C Lozano, R Sotomayor-Zárate, N Meza-Concha, M Arancibia, ... Neural plasticity 2018, 2018 | 22 | 2018 |
| TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration R Ramírez-Barrantes, I Marchant, P Olivero Neural Regeneration Research 11 (8), 1204-1207, 2016 | 21 | 2016 |
| TRPV1-estradiol stereospecific relationship underlies cell survival in oxidative cell death R Ramírez-Barrantes, K Carvajal-Zamorano, B Rodriguez, C Cordova, ... Frontiers in Physiology 11, 522302, 2020 | 14 | 2020 |
| High risk versus proportional benefit: modelling equitable strategies in cardiovascular prevention I Marchant, JP Boissel, P Nony, F Gueyffier Plos one 10 (11), e0140793, 2015 | 7 | 2015 |
| HER2 classification in breast cancer cells: A new explainable machine learning application for immunohistochemistry C Cordova, R Muñoz, R Olivares, JG Minonzio, C Lozano, P Gonzalez, ... Oncology Letters 25 (2), 1-9, 2023 | 6 | 2023 |
| A sudden death risk score specifically for hypertension: based on 25 648 individual patient data from six randomized controlled trials HH Le, F Subtil, M Cerou, I Marchant, M Al-Gobari, M Fall, Y Mimouni, ... Journal of hypertension 35 (11), 2178-2184, 2017 | 6 | 2017 |
| Estrogen rapid effects: a window of opportunity for the aging brain? I Marchant, J Stojanova, L Acevedo, P Olivero Neural Regeneration Research 17 (8), 1629-1632, 2022 | 5 | 2022 |
| Comparison of an effect-model-law-based method versus traditional clinical practice guidelines for optimal treatment decision-making: application to statin treatment in the … R Kahoul, F Gueyffier, E Amsallem, M Haugh, I Marchant, FH Boissel, ... Journal of The Royal Society Interface 11 (100), 20140867, 2014 | 5 | 2014 |
| Estrogen, Cognitive Performance, and Functional Imaging Studies: What Are We Missing About Neuroprotection? IC Marchant, S Chabert, J Martínez-Pinto, R Sotomayor-Zárate, ... Frontiers in Cellular Neuroscience 16, 866122, 2022 | 4 | 2022 |
| Optogenetic control of cancer cell survival in ChR2‐transfected HeLa cells C Córdova, C Lozano, B Rodríguez, I Marchant, R Zúñiga, P Ochova, ... International Journal of Experimental Pathology 102 (6), 242-248, 2021 | 2 | 2021 |
| Towards equitable strategies for hypertension management in cardiovascular prevention I Marchant, F Gueyffier BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 109, 24-24, 2011 | 2 | 2011 |
| [OP. 3B. 01] VALIDATION OF FRAMINGHAM AND SCORE IN 30560 PATIENTS WITH HYPERTENSION H Le, I Marchant, F Subtil, J Boissel, F Gueyffier Journal of Hypertension 35, e28, 2017 | 1 | 2017 |
| Blood pressure lowering in the oldest old: a step toward abandoning arbitrary blood pressure targets F Gueyffier, MI Perez, JM Wright, I Marchant, VM Musini, ... Journal of hypertension 29 (1), 171-173, 2011 | 1 | 2011 |
